Back to Search
Start Over
Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.
- Source :
-
The Biochemical journal [Biochem J] 1990 Mar 01; Vol. 266 (2), pp. 527-35. - Publication Year :
- 1990
-
Abstract
- The CD9 molecule is a 24 kDa surface-membrane glycoprotein present on platelets and a variety of haematopoetic and non-haematopoetic tissues. In the present study we utilized specific inhibitors of thromboxane A2 (TxA2) formation (aspirin), protein kinase C [H-7 [1-(5-isoquinolinesulphonyl)-2-methylpiperazine]] and autocrine stimulation by secreted ADP (apyrase) to modify platelet activation by a monoclonal antibody ALB-6 to the CD9 antigen. This activation is only partially inhibited by aspirin alone but, in combination with either H-7 or apyrase, more than 50% inhibition of platelet aggregation and secretion was observed. This combination of inhibitors was also required to inhibit effectively the phosphorylation of myosin light chain and the 47 kDa substrate of protein kinase C. Intracellular Ca2+ flux monitored by the fluorescent dye fura-2 showed that this was almost completely mediated by the aspirin-sensitive TxA2 pathway. We suggest that the aspirin-insensitive pathway is primarily mediated by phospholipase C formation of diacylglycerol to activate protein kinase C. The inhibition by apyrase suggests a strong dependency on autocrine stimulation by secreted ADP to fully activate both phospholipase C and express fibrinogen-binding sites mediating platelet aggregation. This alternate pathway of phospholipase C activation by ALB-6 may be mediated by cytoplasmic alkalinization [monitored by SNARF-1 (5'(6')-carboxy-10-bismethylamino-3-hydroxy-spiro-[7H- benzo[c]xanthine-1',7(3H)-isobenzofuran]-3'-one) fluorescence of the dye]. Both activation pathways are dependent on intact antibodies, since F(ab')2 fragments of SYB-1, a monoclonal antibody against the CD9 antigen with activation characteristics identical with those of ALB-6, do not elicit activation. Besides thrombin, collagen is another physiological agonist shown to induce aspirin-insensitive activation. Similarities to ALB-6 in collagen sensitivity to apyrase in combination with aspirin inhibitors were noted with respect to aggregation and secretion, as well as a complete block of Ca2+ flux by aspirin. However, it is unlikely that collagen activation is mediated by the CD9 antigen, since SYB-1 F(ab')2 fragments had no effect on collagen activation and aspirin also completely blocked the alkalinization response to collagen, in contrast with ALB-6.
- Subjects :
- 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Adenosine Diphosphate pharmacology
Antibodies, Monoclonal immunology
Aspirin pharmacology
Calcium physiology
Collagen physiology
Humans
Hydrogen-Ion Concentration
Immunoglobulin Fab Fragments
Isoquinolines pharmacology
Phosphoproteins metabolism
Piperazines pharmacology
Platelet Aggregation
Protein Kinase C antagonists & inhibitors
Serotonin metabolism
Signal Transduction
Tetraspanin 29
Thromboxane A2 biosynthesis
Antigens, CD
Antigens, Differentiation physiology
Blood Platelets immunology
Membrane Glycoproteins
Platelet Activation
Platelet Membrane Glycoproteins physiology
Subjects
Details
- Language :
- English
- ISSN :
- 0264-6021
- Volume :
- 266
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- The Biochemical journal
- Publication Type :
- Academic Journal
- Accession number :
- 2317202
- Full Text :
- https://doi.org/10.1042/bj2660527